122 related articles for article (PubMed ID: 4007023)
1. Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: study based on the clinicopathologic relations found in the EORTC trial (20751).
De Wolf-Peeters C; Caillou B; Diebold J; van Heerde P; van Unnik JA; van den Oord JJ; van Glabbeke M; Somers R
Eur J Cancer Clin Oncol; 1985 May; 21(5):579-84. PubMed ID: 4007023
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
[TBL] [Abstract][Full Text] [Related]
3. A new working formulation of non-Hodgkin's lymphomas. A retrospective study of the new NCI classification proposal in comparison to the Rappaport and Kiel classifications.
Krueger GR; Medina JR; Klein HO; Konrads A; Zach J; Rister M; Janik G; Evers KG; Hirano T; Kitamura H; Bedoya VA
Cancer; 1983 Sep; 52(5):833-40. PubMed ID: 6871825
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.
Monfardini S; Rilke F; Valagussa P; Bajetta E; Canetta R; Buzzoni R; Giardini R; Viviani S
Eur J Cancer Clin Oncol; 1984 May; 20(5):609-17. PubMed ID: 6203753
[TBL] [Abstract][Full Text] [Related]
5. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.
Cancer; 1982 May; 49(10):2112-35. PubMed ID: 6896167
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphomas: a simplified classification scheme.
Krueger GR; Papadakis T; Medina JR
Anticancer Res; 1984; 4(3):103-8. PubMed ID: 6465846
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of three pathologic classifications (Rappaport, LSG and Working Formulation) for the treatment of non-Hodgkin's lymphoma].
Shibuya H; Kamiyama R; Umehara I; Okada Y; Sato S; Yoshimatsu S; Horiuchi J; Suzuki S
Gan No Rinsho; 1985 Nov; 31(14):1757-61. PubMed ID: 4087381
[TBL] [Abstract][Full Text] [Related]
8. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
Byrne GE
Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
[TBL] [Abstract][Full Text] [Related]
9. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.
Gerdes J; Dallenbach F; Lennert K; Lemke H; Stein H
Hematol Oncol; 1984; 2(4):365-71. PubMed ID: 6396192
[TBL] [Abstract][Full Text] [Related]
10. A retrospective clinico-pathologic study of non-Hodgkin's lymphomas classified according to the nomenclatures of Lennert and of Rappaport.
Cavallin-Ståhl E; Landberg T; Lindberg LG; Akerman M
Acta Med Scand; 1981; 209(5):407-14. PubMed ID: 7246275
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of mean cell volume in non-Hodgkin's lymphomas.
Hauser L; Kurec A; Goldberg J; Dubowy RL; Davey FR
Cancer; 1986 Jun; 57(12):2363-7. PubMed ID: 3697936
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
[TBL] [Abstract][Full Text] [Related]
13. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
Stacher A; Heinz R; Waldner R; Böhnel J
Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
[TBL] [Abstract][Full Text] [Related]
14. A critique of some contemporary classifications of non-Hodgkin's lymphoma. Which one should we now use?
Leong AS
Pathology; 1983 Oct; 15(4):437-42. PubMed ID: 6371682
[TBL] [Abstract][Full Text] [Related]
15. A critical analysis of the classifications of non-Hodgkin's lymphomas.
Nathwani BN
Cancer; 1979 Aug; 44(2):347-84. PubMed ID: 383253
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the Working Formulation.
Percy C; O'Conor G; Ries LG; Jaffe ES
Cancer; 1984 Oct; 54(7):1435-8. PubMed ID: 6467164
[TBL] [Abstract][Full Text] [Related]
17. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period.
Ho FC; Todd D; Loke SL; Ng RP; Khoo RK
Int J Cancer; 1984 Aug; 34(2):143-8. PubMed ID: 6381328
[TBL] [Abstract][Full Text] [Related]
18. The influence of histologic type on survival in early extranodal non-Hodgkin's lymphoma in head and neck.
Aozasa K; Nara H; Ikeda H; Masaki N; Miyata Y; Matsuzuka F; Shigematsu Y
Oncology; 1984; 41(3):164-9. PubMed ID: 6728399
[TBL] [Abstract][Full Text] [Related]
19. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
20. Relation between enzymatic activities and the degree of malignancy of human lymphomas.
Vezzoni P; Giardini R; Raineri M; Pozzi MR; Lucchini R; Vezzoni MA; Clerici L; Besana C; Rugarli C; Rilke F
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):945-50. PubMed ID: 4043177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
